Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kevin Walsh | M | - |
Global Life Technologies Corp.
 Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| Philippe Touret | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| Eric Lauzat | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
| Stephen Willard | M | 63 |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- John Willimann
- Persönliches Netzwerk
